Cascade Investment Advisors, Inc.

Position in SNY — Sanofi

CIK 1681490 Oregon City, OR

Position in SNY

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$1,635,712

-$184,191 QoQ

Shares Held

38,343

+1.5% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.97%

of 13F equity value

Holder Rank

#206

of 712 holders

Holding Since

Mar 2021

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Cascade Investment Advisors, Inc. holds $9,129,364 across 5 Drug Manufacturers - General names. SNY ranks #3 (17.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NVS	Novartis AG	20,060	$3,143,803
2	JNJ	Johnson & Johnson	9,319	$2,366,746
3	SNY	Sanofi This page	38,343	$1,635,712
4	PFE	Pfizer Inc	67,874	$1,634,405
5	GILD	Gilead Sciences, Inc.	2,760	$348,698

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,635,712	38,343	+1.5%	Shares	Sole	2026-07-15
2026-03-31	$1,819,903	37,773	+1.8%	Shares	Sole	2026-04-13
2025-12-31	$1,797,284	37,088	+1.2%	Shares	Sole	2026-01-14
2025-09-30	$1,730,493	36,663	+6.1%	Shares	Sole	2025-10-09
2025-06-30	$1,668,820	34,544	+0.5%	Shares	Sole	2025-07-25
2025-03-31	$1,906,104	34,369	-3.1%	Shares	Sole	2025-04-08
2024-12-31	$1,710,669	35,469	+0.4%	Shares	Sole	2025-01-22
2024-09-30	$2,035,433	35,319	+0.5%	Shares	Sole	2024-10-02
2024-06-30	$1,705,914	35,159	+2.3%	Shares	Sole	2024-07-08
2024-03-31	$1,669,847	34,359	+4.7%	Shares	Sole	2024-04-25
2023-12-31	$1,632,337	32,824	+41.0%	Shares	Sole	2024-01-11
2023-09-30	$1,248,953	23,284	+15422.7%	Shares	Sole	2023-10-30
2021-06-30	$7,899	150	0.0%	Shares	Sole	2021-08-04
2021-03-31	$7,419	150	—	Shares	Sole	2021-04-23
No filing history on record for this holder in this stock.